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Summary
There is a wide range of potential study designs suitable for intervention stud-
ies to decrease health-care associated infections in hospitals. The most popular
are pre-post quasi-experimental designs which are often chosen when cluster ran-
domization was not feasible. However, randomization can be done in several
ways: randomization of the cluster (intensive care unit or hospital) in a parallel
design, randomization of the sequence in a cross-over design, and randomization
of the timing in a stepped-wedge design. We introduce each design in the context
of health-care associated infections and discuss the designs with respect to fol-
lowing key points: bias, control for nonintervention factors, randomization, the
estimated intervention effect (within-cluster and between-cluster), generalizabil-
ity and sample size. We conclude that investigators should weight the benefits of
randomization to yield internally valid results. General, the first choice in terms
of the internal validity should be a parallel cluster randomized trial. But then, in
infection control studies, we think that the generalizability might be stronger in
a stepped-wedge design because a wider range of ICU clinicians can be convinced
to participate when some pilot studies already showed promising results.
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Introduction
The effective control of health-care associated infections (HAIs) is one of the
most important priorities for public health action in hospitals. There are many
interventions to control, especially antibiotic-resistant, infections. Examples are:
implementation of guidelines, controlled antibiotic stewardship, improved hygiene
practices, isolation of infected patients, and universal screening at hospital ad-
mission. The use of strategic bundles of evidence-based procedures has had some
success in reducing HAIs for instance, in controlling catheter-related bloodstream
infections in the ICU1,2.
The proof whether an intervention is successful is rather challenging and requires
at least one study with an appropriate design. Shardell and colleagues3 gave a
nice overview about quasi experiments to antimicrobial resistance intervention
studies. In this paper, we extend their approach and discuss randomization in
several aspects: randomization of the cluster (intensive care unit or hospital) in a
parallel design, randomization of the sequence in a cross-over design, and random-
ization of the timing in a stepped-wedge design. Examples should demonstrate
that these designs are performed in intervention studies to reduce HAIs.
Motivation
According to Grimes and Schulz, clinicians should face two important questions
when they read medical research: ”Is the report believable, and, if so, is it rel-
evant to my practice?”4. However, the interpretation of published intervention
studies can be difficult. How shall we interpret the main conclusion of a study
that a specific intervention ”... can lead to a dramatic decrease in the incidence of
primary bloodstream infections”5 if this conclusion is based on a single intensive
care unit (ICU) with 18 beds? The answer is that the conclusion above is valid
for one ICU only and is not generalizable to other ICUs. In such a study, the
incidence of primary bloodstream infections has been collected many repeated
times pre- and post intervention and the statistical analysis controls for the vari-
ation within the ICU. There is, however, a variation between ICUs which needs
also to be controlled before making general statements for other ICUs.
Outcome definition
There are several definitions of outcome in these intervention studies. A well-
established definition is the incidence rate of infection which is collected in monthly
records (e.g. number of new MRSA infections per 1000 patient-days). The most
suitable denominator is often patient-days, but others are also suitable depending
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of the outcome of interest, e.g. number of patients, catheter-days for catheter-
related blood stream infections or ventilation-days for ventilator-associated pneu-
monia. An alternative to the incidence rate could be the transmission index which
is defined as the ratio between secondary and imported MRSA cases6. Another
option is to study interventions to increase the compliance to evidence-based
guidelines7–10. In this article, we want to address issues which holds for any type
of outcomes which are measured repeatedly over time. In the following, we use
the term “infection rates” for incidence rates of infection.
Even though one is primarily interested in incidence rates of infections, one should
keep in mind that discharge from the hospital or dying in the hospital are com-
peting events for health-care associated infections11. Thus, secondary outcomes
are often monthly records of mean length of hospital/unit stay or mortality rates.
Level of inference
The level of inference is crucial. Even though randomized trials at a patient
level exists in this field12, due to the potentially complex transmission pattern,
it is often not feasible to measure intervention effects on the individual patient
level13. Therefore, we assume trials which are intended to evaluate interventions
at the hospital or at the ICU level. In this case, the hospital or the ICU is the
unit of inference and sample size estimation and analysis apply at the hospital
/ ICU level. In the following, we use the term cluster for hospital or ICU. From
a statistical point of view, clusters require a special attention since individual
patients within a hospital are correlated and thus not independent.
Bias in intervention studies to control HAI
Intervention studies to control health-care associated infections have a specific
challenge, the Hawthorn effect: health-care workers might improve their behav-
ior (e.g. in hygiene practices) simply in response to the fact that they are being
studied and not in response to the intervention. For instance, Kohli et al14 ex-
plored it with respect to hand hygiene performance. This effect is a problem in
all designs which only consider within-cluster comparisons. It could be addressed
by adding a control group and assuming that the Hawthorn effect acts on the
intervention as well as on the control group with the same intensity. This un-
wanted effect can further be limited with randomized group assignment.
The choice of a control group can be inappropriate in the sense that the inter-
vention and the control group are not comparable. This selection bias can be
avoided if the groups are similar in all important respects4 such as the baseline
infection rate, the size of cluster (number of beds in the ICU/hospital), specialty
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of the cluster (surgical or medical ICU), overall patient-days, average length of
stay and mortality rates.
Another challenge is to control for nonintervention factors which have an impact
on the outcome (e.g., incidence rate of infection). Examples are a general better
understanding of HAI infections (which usually increases with calendar time) and
an implementation of new guidelines to control HAI (which is independent of the
intervention of interest).
Designs
Figure 1 is a schematic presentation of the five designs: pre-post intervention, pre-
post intervention with control, parallel-, cross-over- and stepped-wedge cluster
randomized.
Design A: Pre-post intervention
The most popular approach is a pre-post quasi-experimental design without any
type of randomization (Figure 1 A). There is a control period where baseline
data of monthly records of infection rates are collected (pre-intervention data).
Then, after a certain time (usually about 12 until 36 months), there is the in-
tervention on the cluster level. After the intervention, post-treatment data are
collected for a certain period (usually about the same period as before the inter-
vention). These data are best analyzed with interrupted time series regression
models3. Interrupted time series studies allow health systems researchers to es-
timate whether and how much an intervention changed the infection rates. They
are suitable to show whether these effects occurred immediately after the inter-
vention or with delay and whether effects are long term15. They are particular
useful for interventions in outbreak settings and recommended by the ORION
statement16,17.
Control for bias and nonintervention factors
In this design inference is made by within-cluster comparison. This has the ad-
vantage that it controls for cluster-specific factors (such as hospital size, average
length of stay (or patient-days as the combination of both), mortality rates etc.)
since each cluster is its own control. However, it should be checked (and reported)
whether these factors are changing very much during the study period, especially
whether the intervention influence these factors.
The main disadvantage is that the results might be biased through the Hawthorn
effect. Further, it is not clear whether an estimated intervention effect was ac-
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tually due to calendar-time-related factors such as an increased awareness with
respect to the HAI.
One major disadvantage is the limited generalizability. Often only a small num-
ber (between one and three) of clusters are included in the study. In this case and
assuming that there are no calendar-time-related factors, inference is only valid
for these clusters (which might be enough for, e.g., a large hospital) but there
is a lack of generalizability18. That means that a significant intervention effect
is not in principle generalizable to others: the intervention might work for this
specific cluster but not for others. One reason might be the variation in baseline
infection rates.
Sample size and power
According to Zhang15, interrupted time series regression models have more than
80% power to detect effect sizes of 1.0 or greater in a range of situations with 24 or
more time points, depending on the complexity of the model and assuming that
there are no nonintervention factors which influence the infection rate. Shardell
et al. give a general rule of thumb to have at least 50 time points to estimate
complex correlation structures3. In general, increasing the number of time points
increases the power of the study. As Zhang et al, we recommend conducting
various simulations before investigation.
Possible improvements
An example for a thorough analysis of an interrupted time series is the study
made by Fowler et al19. They investigated the impact of guidelines and enhanced
antibiotic stewardship to reduce the incidence of Clostridium difficile infection.
In addition, they also used MRSA rates as a secondary outcome; this approach
is closely related to the idea of a negative control20 since it was thought unlikely
that this rate would change due to the intervention. So an association between
the guidelines and this infection would be a warning that there may be residual
confounding due to some other contemporary change. Another improvement is
adding a control group which is discussed in the following section.
Design B: Pre-post intervention with control group
Using only one intervention group allows to estimate within-group effects, i.e.,
infection rates of intervention and control period are compared within hospi-
tals/units. The intervention effect is exclusively estimated from within-cluster
comparisons.
By adding a control group (Figure 1 B), within-cluster differences over time are
then compared between clusters. It helps to identify and control general factors
which are independent of the intervention (e.g. a decrease of infection rate due
to other factors).
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Control for bias and nonintervention factors
This design has the same advantages as the previous design. In addition, one has
the possibility to observe the shape of the infection rate without the intervention.
This is one way to address the Hawthorn effect and to avoid spurious conclusions.
In an example by Shardell et al.3, the MRSA infection rate in the intervention
group decreases by 0.8 cases per 1000 person-days after intervention, but in the
control group the rate decreases by 0.6 cases per 1000 person-days. They con-
cluded that the, ”decrease in the MRSA infection rate is partially attributable
to nonintervention factors, which could not have been identified without a con-
trol”3.
The main disadvantage of this design is that the results and conclusions are prone
to selection bias due to an inappropriate control selection. The control group
should contain clusters which are very similar to the intervention group. Espe-
cially the baseline incidence rates of the infection of interest, but also the average
length of stay and in-hospital mortality rates should be comparable. Other issues
might be the size of the hospital, overall patient-days or, e.g., ventilator-days for
studies on ventilator-associated pneumonia.
Sample size and power
In studies of health-care associated infections, it is usually the case that the
variability of incidence rates taken from different clusters (between-group) is far
greater than the variability of incidence rates repeated over time taken from
the same clusters (within-group). Researchers should keep in mind that the
power increases much more with an increasing number of clusters than with an
increasing number of subjects within clusters21.
Possible improvements
This design can be extended when the assignment to the intervention or the
control group is randomized. The additional advantages are described in the
next section.
Design C: Parallel cluster randomized trial
Interventions to decrease health-care associated infections are usually performed
on unit or hospital level (cluster) and in a cluster randomized trial patients are
randomized in these clusters rather than individually.
In the parallel design the clusters are randomly assigned either to the interven-
tion or the control group at a single time point (Figure 1 C). This randomization
assures that selection bias play no role in the assignment of clusters to inter-
ventions and the formal justification for the applied statistical model21. With a
sufficient number of clusters it allows to generalize the intervention effect to other
hospitals. This, however, highly depends on the inclusion criteria which could be
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rather strict.
Control for bias and nonintervention factors
This design is suitable to estimate between-cluster effects and hence controls for
confounders. Selection bias is avoided. Thus, it has a high degree of internal
validity.
Sample size and power
This design requires (in contrast to the other designs discussed in this paper) a
large sample size since the intervention effect is exclusively estimated between
clusters. As mentioned before, the variability of incidence rates between clus-
ters is usually larger than the variability within clusters. A large between-cluster
variability leads to an inflation of the required sample size, especially when in-
vestigating the effect of intervention on relatively rare events. The power of a
parallel cluster randomized trial depends more on the number of clusters ran-
domized than on their size21. If the number of clusters of the intervention group
cannot be increased due to economic reasons, one might think about increasing
the numbers of clusters of the control group. There might be a potential gain
in power which should be explored with e.g. simulations. We refer to Donner
and Klar for further hints to increase the power and details to the statistical
analysis21; we also refer to Eldridge et al22.
Possible extensions
This design can be improved when (after randomization) pre-intervention data
are collected. That would be a combination of two designs B and C. Furthermore,
as described in design A, one could collect and analyze secondary outcomes as
negative controls19,20.
Design D: Cross-over cluster randomized trial
A cross-over trial is distinguished from a parallel design by each cluster receiving
a sequence of experimental treatments23 (figure 1 D). That means that clusters
are randomly assigned to a sequence of treatments (first control period, second
intervention period or first intervention period, second control period).
Between each change (between control and intervention period or vice versa) there
is a pre-defined wash-out period which controls potential carry-over effects23. The
duration of the wash-out period should be chosen in the way that the effect of
a treatment given in one period to be washed out before each cluster began
the next period of treatment. Thus, the design is often not suitable for specific
interventions, e.g., if the intervention is based on education or if there is a delayed
intervention effect.
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Control for bias and nonintervention factors
This design is suitable to estimate between-cluster effects as well as within-cluster
effects. It controls for cluster-specific factors as described for design A. The
randomization controls period-specific confounding factors (e.g. a publication of
new infection control guidelines on a specific calendar date).
Sample size and power
The main advantage is that it requires fewer clusters than the parallel design
because of the reduction in variance due to examining within-cluster changes.
The main disadvantage is that the study period is usually more than twice as
long as the parallel design, since within each cluster one collects data from the
control, intervention and wash-out period. We refer to Turner et al24 for details
to the statistical analysis using hierarchical models.
Possible improvements
As described in design A, one could collect and analyze secondary outcomes as
negative controls19,20.
Design E: Stepped-wedge cluster randomized trial
A stepped-wedge design is a type of cross-over design but the clusters cross over
at different time points and in one direction only, from a control to interven-
tion period25 (Figure 1 E). The time at which a cluster starts the intervention
is randomized25,26. Once a clusters has received the intervention, it is never re-
moved. This makes the stepped wedge design particularly useful for evaluating
the population-level impact of an intervention that has been shown to be effective
in an individually randomized trial25. For instance, there are evidence-based pro-
cedures recommended by the Centers for Disease Control and Prevention (CDC)
and identified as having a reducing effect on the rate of catheter-related blood-
stream infection1. This design is suitable for interventions where previous evi-
dence is limited to promising results in small trials, and there is a strong belief
that the intervention will do more good than harm27.
Control for bias and nonintervention factors
This design is suitable to estimate between-cluster effects as well as within-cluster
effects. It controls for cluster-specific factors as described for design A. The
randomization controls nonintervention factors which depend on calendar time
(e.g. a publication of new infection control guidelines on a specific calendar date).
Sample size and power
The number of clusters randomized at each time step influences the power of the
study. The optimal power is achieved when each cluster is randomized at its own
randomization step a different time25, i.e., each hospital begins the intervention
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at different time points. This is often not feasible and multiple clusters often want
to start the intervention at the same time. Hussey and Hughes25 demonstrate in
a simulation study that, for a fixed number of clusters, power decreases as the
number of randomization steps decreases.
Possible improvements
As described in design A, one could secondary outcomes as negative controls19,20.
Discussion
We compared five designs to examine the effect of interventions on hospital-
acquired infections with respect to bias, control for nonintervention factors, dif-
ferent types of randomization, type of estimated intervention effect, generaliz-
ability and sample size.
Given this overview, the choice of the most suitable study design for a given re-
search question remains challenging. A pre-post intervention design is often the
only choice and informative for a retrospective analysis of an outbreak setting.
It can be seen as a pilot study. Adding a control group is highly recommended
to control for nonintervention factors and address the Hawthorn effect. To avoid
the selection bias by choosing inappropriate control clusters, it is recommended
to randomize the assignment of clusters. Because of carry-over effects, cross-over
designs are only suitable for very specific interventions. The negative control
approach19,20 is very suitable but might be restricted to interventions controlling
specific pathogens only.
The choice between the parallel and stepped-wedge design has recently been dis-
cussed28,28,29. Kotz et al. favor the use of the parallel over the stepped-wedge de-
sign. We agree that parallel design should be in principle the first choice in terms
of the hierarchy of evidence (internal validity). But then, in infection control
studies, we think that the generalizability might be stronger in a stepped-wedge
design because a wider range of ICU clinicians can be convinced to participate
when some pilot studies (design A) already showed promising results.
This overview has limitations. There are further challenges of intervention stud-
ies which go beyond the scope of this article. We did not discuss the problem
of over-dispersion of transmission-associated infections (such as MRSA)30. We
considered the intervention on the cluster level by assuming that the cluster char-
acteristics do not change over study time. However, patients within the clusters
are changing over study time (via admission and discharge). This may intro-
duce confounding in the study of the intervention. If data were collected at the
patient-individual level, those factors could be taken into account by appropri-
ate regression models (such as multi-level, random effects or hierarchical) using
individual data (see Diez-Roux31 and Koopman and Longini13). Furthermore,
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getting individual-level data also means that one could address interactions, e.g.,
if the intervention acts only for specific patient groups. The ORION guidelines
already state that analysis of aggregated data should be avoided when disaggre-
gated data are available17.
In awareness that there are many barriers to key features of randomized controlled
trials32 in infection control studies, investigators should weight the benefits of ran-
domization in terms of internal validity and the resulting inference. There are
established multi-center and international surveillance studies33,34 where longitu-
dinal data were collected since several years. These networks might have a great
potential to perform well-designed intervention studies. We hope that this paper
helps to guide researchers working in infection control in planning and designing
such studies. In accordance with Mdege et al27 we emphasize that there is a need
for a better reporting and a more consistent data analysis. An extension of the
Consolidated Standards of Reporting Trials (CONSORT) statement is given for
cluster randomized trials35.
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Figure 1: Schematic presentation of different designs for intervention studies to
decrease health-care associated infections. The intervention period is marked in
grey. Both groups (intervention and control) usually contain several clusters.
Study period usually differs between designs (see Table 1).
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